Gene · 6360
CCL16: C-C motif chemokine ligand 16
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CCL16: C-C motif chemokine ligand 16. Genes, record 6360. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6360
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O15467 | C-C motif chemokine 16 | 120 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents126
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026120675 A | 2026-07-22 | 732 | O15467 | Espacenet |
| EP 4705273 A2 | 2026-03-11 | 406 | O15467 | Espacenet |
| EP 4705273 A2 | 2026-03-11 | 414 | O15467 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 41003 | O15467 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 18295 | O15467 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 2130 | O15467 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 16626 | O15467 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 18295 | O15467 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 2130 | O15467 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 16626 | O15467 | Espacenet |
1 to 10 of 126
See all 126 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,278
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CCL16 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P2CHD050924 | Carolina Population Center | 4 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 4 | 2025 |
| R01AI121209 | Cooperation between lymphatic stroma and hematopoietic cells shapes protective immunity | 4 | 2025 |
| T32CA009686 | Training Grant In Tumor Biology | 4 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 4 | 2025 |
| P01AG026276 | Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study | 3 | 2025 |
| P30AI027757 | University of Washington/Fred Hutch Center for AIDS Research | 3 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,278Source NIH's project files
See all 1,278 nih grantsPapers1,677
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distributed cortical learning through LEC-mediated γ-synchrony. | Nat Commun | 2026 | 42816474 | PubTator, text mining | PubMed |
| NAD+-sirtuin-mitochondrial quality control in lens epithelial cells: a candidate modulatory network in crystalline lens aging. | Exp Eye Res | 2026 | 42764115 | PubTator, text mining | PubMed |
| Integrated analyses of single-cell transcriptome and mendelian randomization reveal the role of lymphatic endothelial CD74 in the progression of atherosclerosis. | J Geriatr Cardiol | 2026 | 42740889 | PubTator, text mining | PubMed |
| Carbohydrate-derived multifunctional liquefied cellulose as reactive polyol and filler for high-performance waterborne polyurethane: Toward sustainable wood coatings. | Int J Biol Macromol | 2026 | 42632500 | PubTator, text mining | PubMed |
| Lymphatic Endothelial Cells in Health and Disease. | MedComm (2020) | 2026 | 42517067 | PubTator, text mining | PubMed |
| Senescence Gene Expression Profiles and 90-Day Outcome in Stroke Patients. | Neurology | 2026 | 42479998 | PubTator, text mining | PubMed |
| Neurotensin receptor 2 agonism attenuates adverse cardiac remodeling in preclinical models. | Sci Transl Med | 2026 | 42384771 | PubTator, text mining | PubMed |
| Lens epithelial cell damage and reduced aquaporin-1 immunoreactivity in liquefied mature cataracts. | Graefes Arch Clin Exp Ophthalmol | 2026 | 42371027 | PubTator, text mining | PubMed |
| The Scaffold Protein Liprin β-1 (PPFIBP1) and the Intermediate Filament Synemin: Potential New Markers of Lymphatic Endothelial Cells. | Cells | 2026 | 42346091 | PubTator, text mining | PubMed |
| Rapid discovery of cell-surface glycosylation regulators using a lectin-based magnetic CRISPR screen. | Cell Rep Methods | 2026 | 42341757 | PubTator, text mining | PubMed |
1 to 10 of 1,677
See all 1,677 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6360
GET https://conductscience.org/api/genes/v1/6360/patents?page=2